Peter M Luckett

Medicine & Life Sciences

1. Pediatrics 100%
2. Child 80%
3. Critical Illness 69%
4. Endothelial Cells 62%
5. Respiratory Insufficiency 55%
6. Mechanical Ventilators 49%
7. Randomized Controlled Trials 42%
8. Lung 42%
9. Ventilator Weaning 42%
10. High-Frequency Ventilation 38%
11. Spinal Muscular Atrophy 35%
12. Pediatric Intensive Care Units 34%
13. Hepatocyte Growth Factor 32%
14. Insulin 31%
15. Weaning 29%
16. Critical Care 28%
17. Candida albicans 27%
18. Asthma 26%
19. Clinical Decision Support Systems 25%
20. Heart Failure 23%
21. Traumatic Brain Injury 22%
22. Hypersensitivity 22%
23. Health Care Outcome Assessment 22%
24. bactericidal permeability increasing protein 21%
25. Congenital Myasthenic Syndromes 21%
26. Status Asthmaticus 20%
27. Clinical Trials 20%
28. Cattle 20%
29. Heart Rate 19%
30. Quality of Life 19%
31. Glucose 18%
32. Terbutaline 18%
33. Acute Lung Injury 18%
34. Lung Volume Measurements 17%
35. Hypoventilation 17%
36. Noninvasive Ventilation 17%
37. Early Ambulation 16%
38. Brain Injuries 16%
39. Amnion 16%
40. Wounds and Injuries 16%
41. Population 16%
42. Eicosanoids 16%
43. Albuterol 16%
44. Creatine 15%
45. Nebulizers and Vaporizers 15%
46. Ibuprofen 15%
47. Craniocerebral Trauma 15%
48. Blood Glucose 15%
49. Epoprostenol 15%
50. Acetylcholinesterase 14%